Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 21, 2022
Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myelomaBhavesh Shah, Joy Gray, Ivo Abraham, et al.
Journal of Medical Economics|October 7, 2020
Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqvKaren MacDonald, Ali McBride, Neda Alrawashdh, et al.
Future Oncology (London, England)|November 8, 2021
Expanded access to anticancer treatments from conversion to biosimilar pegfilgrastim-cbqv in US breast cancer patientsAli McBride, Neda Alrawashdh, Karen MacDonald, et al.
Future Oncology (London, England)|August 12, 2021
Conversion to biosimilar pegfilgrastim-cbqv enables budget-neutral access to FOLFIRINOX treatment for metastatic pancreatic cancerKaren MacDonald, Neda Alrawashdh, Ali McBride, et al.
Current Opinion in Supportive and Palliative Care|December 1, 2012
Analytical methods and issues for symptom cluster research in oncologyHee-Ju Kim, Ivo Abraham, Patrick S Malone
JCO Clinical Cancer Informatics|June 8, 2019
Center-Specific Modeling Predicts Cancer Trial Accrual More Accurately Than Investigators and Random Effects Modeling at 16 Cancer CentersWendy R Tate, Ivo Abraham, Lee D Cranmer
British Journal of Hospital Medicine (London, England : 2005)|June 24, 2025
The Clinical and Economic Value of Follow-on Biologics: Biosimilars, Biobetters, and BioparallelsIvo Abraham, Ansam Nail Beddor, Karen Michelle MacDonald
Therapeutic Advances in Medical Oncology|May 17, 2012
Comparative cost efficiency across the European G5 countries of originators and a biosimilar erythropoiesis-stimulating agent to manage chemotherapy-induced anemia in patients with cancerMatti Aapro, Paul Cornes, Diana Sun, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2016
Risk of Atrial Fibrillation and Bleeding Diathesis Associated With Ibrutinib Treatment: A Systematic Review and Pooled Analysis of Four Randomized Controlled TrialsSeongseok Yun, Nicole D Vincelette, Utkarsh Acharya, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|October 2, 2014
Emergency department visits in the United States for pediatric depression: estimates of charges and hospitalizationDiana Sun, Ivo Abraham, Marion Slack, et al.
Pageof 23